发明授权
- 专利标题: Anti-cancer agent
-
申请号: US14494637申请日: 2014-09-24
-
公开(公告)号: US09700572B2公开(公告)日: 2017-07-11
- 发明人: Hiroyasu Esumi , Masafumi Ikeda , Chika Miyoshi , Shigetoshi Kadota , Toshiki Okubo , Satoshi Yomoda , Takafumi Fuse , Takanori Kawashima , Shigeki Chiba
- 申请人: Kracie Pharma, Ltd. , NATIONAL CANCER CENTER , National University Corporation University of Toyama
- 申请人地址: JP Tokyo JP Tokyo JP Toyama
- 专利权人: National Cancer Center,Kracie Pharma, Ltd.,National University Corporation University of Toyama
- 当前专利权人: National Cancer Center,Kracie Pharma, Ltd.,National University Corporation University of Toyama
- 当前专利权人地址: JP Tokyo JP Tokyo JP Toyama
- 代理机构: Sunstein Kann Murphy & Timbers LLP
- 优先权: JP2012-069964 20120326
- 主分类号: A61K31/7048
- IPC分类号: A61K31/7048 ; A61K31/7034 ; A61K31/341 ; A61K31/365 ; A61K36/28
摘要:
The present invention is intended to provide a novel anticancer agent which is effective to a cancer. After administering an agent prepared using burdock fruit extract to a pancreas cancer patient so that a dose of arctigenin was 100 mg or more per day, the tumor reducing effect was observed, and, in addition, lowering of tumor markers was confirmed. The present invention provides an anticancer agent containing arctigenin, wherein a dose of the arctigenin is 100 mg or more per day. In addition, the present invention provides the anticancer agent containing arctigenin and arctiin at a weight ratio of arctigenin/arctiin=0.7 to 1.3.
公开/授权文献
- US20150196576A1 Anti-Cancer Agent 公开/授权日:2015-07-16
信息查询